Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Interest & Investment Income: 2009-2013

Historic Interest & Investment Income for Cytokinetics (CYTK) over the last 3 years, with Dec 2013 value amounting to $101,000.

  • Cytokinetics' Interest & Investment Income rose 206.06% to $101,000 in Q4 2013 from the same period last year, while for Dec 2013 it was $187,000, marking a year-over-year decrease of 99.60%. This contributed to the annual value of $156,000 for FY2015, which is 44.44% up from last year.
  • As of Q4 2013, Cytokinetics' Interest & Investment Income stood at $101,000, which was up 320.83% from $24,000 recorded in Q3 2013.
  • Cytokinetics' Interest & Investment Income's 5-year high stood at $46.3 million during Q1 2011, with a 5-year trough of $15,000 in Q2 2012.
  • Moreover, its 3-year median value for Interest & Investment Income was $30,000 (2012), whereas its average is $6.6 million.
  • As far as peak fluctuations go, Cytokinetics' Interest & Investment Income slumped by 33.33% in 2010, and later surged by 23,057.42% in 2011.
  • Cytokinetics' Interest & Investment Income (Quarterly) stood at $112,000 in 2009, then decreased by 10.71% to $38,000 in 2010, then spiked by 23,057.42% to $46.3 million in 2011, then reached $33,000 in 2012, then spiked by 206.06% to $101,000 in 2013.
  • Its Interest & Investment Income stands at $101,000 for Q4 2013, versus $24,000 for Q3 2013 and $29,000 for Q2 2013.